RWL vs. HROW

Last updated Apr 1, 2026

Compare and contrast key facts about Invesco S&P 500 Revenue ETF (RWL) and Harrow Health, Inc. (HROW).

RWL is a passively managed fund by Invesco that tracks the performance of the S&P 500 Revenue-Weighted Index. It was launched on Feb 19, 2008.

Performance

RWL vs. HROW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P 500 Revenue ETF (RWL) and Harrow Health, Inc. (HROW). The values are adjusted to include any dividend payments, if applicable.

RWL vs. HROW - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RWL Invesco S&P 500 Revenue ETF	0.74%	18.65%	16.45%	17.43%	-6.00%	30.29%	9.14%	27.83%	-7.74%	20.34%
HROW Harrow Health, Inc.	-28.04%	46.05%	199.55%	-24.12%	70.83%	25.95%	-11.83%	36.73%	234.71%	-32.00%

Returns By Period

In the year-to-date period, RWL achieves a 0.74% return, which is significantly higher than HROW's -28.04% return. Over the past 10 years, RWL has underperformed HROW with an annualized return of 12.99%, while HROW has yielded a comparatively higher 24.47% annualized return.

RWL

• 1D: 2.04%
• 1M: -4.73%
• YTD: 0.74%
• 6M: 4.59%
• 1Y: 17.35%
• 3Y*: 16.48%
• 5Y*: 12.15%
• 10Y*: 12.99%

HROW

• 1D: 5.89%
• 1M: -34.92%
• YTD: -28.04%
• 6M: -26.82%
• 1Y: 32.56%
• 3Y*: 18.56%
• 5Y*: 39.02%
• 10Y*: 24.47%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RWL vs. HROW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RWL

RWL Risk / Return Rank: 71
RWL Sharpe Ratio Rank: 69
RWL Sortino Ratio Rank: 69
RWL Omega Ratio Rank: 70
RWL Calmar Ratio Rank: 67
RWL Martin Ratio Rank: 78

HROW

HROW Risk / Return Rank: 60
HROW Sharpe Ratio Rank: 60
HROW Sortino Ratio Rank: 59
HROW Omega Ratio Rank: 59
HROW Calmar Ratio Rank: 61
HROW Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RWL vs. HROW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500 Revenue ETF (RWL) and Harrow Health, Inc. (HROW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RWL	HROW	Difference
Sharpe ratio Return per unit of total volatility	1.15	0.50	+0.65
Sortino ratio Return per unit of downside risk	1.68	1.12	+0.56
Omega ratio Gain probability vs. loss probability	1.25	1.15	+0.10
Calmar ratio Return relative to maximum drawdown	1.64	0.88	+0.76
Martin ratio Return relative to average drawdown	7.90	2.29	+5.62
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RWL vs. HROW - Sharpe Ratio Comparison

The current RWL Sharpe Ratio is 1.15, which is higher than the HROW Sharpe Ratio of 0.50. The chart below compares the historical Sharpe Ratios of RWL and HROW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RWL	HROW	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.15	0.50	+0.65
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.84	0.56	+0.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.77	0.35	+0.42
Sharpe Ratio (All Time) Calculated using the full available price history	0.55	-0.04	+0.60

Correlation

The correlation between RWL and HROW is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

RWL vs. HROW - Dividend Comparison

RWL's dividend yield for the trailing twelve months is around 1.38%, while HROW has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RWL Invesco S&P 500 Revenue ETF	1.38%	1.35%	1.43%	1.60%	1.62%	1.35%	1.75%	1.87%	1.99%	1.60%	1.71%	1.97%
HROW Harrow Health, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

RWL vs. HROW - Drawdown Comparison

The maximum RWL drawdown since its inception was -54.83%, smaller than the maximum HROW drawdown of -99.46%. Use the drawdown chart below to compare losses from any high point for RWL and HROW.

Drawdown Indicators

	RWL	HROW	Difference
Max Drawdown Largest peak-to-trough decline	-54.83%	-99.46%	+44.63%
Max Drawdown (1Y) Largest decline over 1 year	-11.26%	-39.27%	+28.01%
Max Drawdown (5Y) Largest decline over 5 years	-17.49%	-71.15%	+53.66%
Max Drawdown (10Y) Largest decline over 10 years	-36.04%	-71.15%	+35.11%
Current Drawdown Current decline from peak	-4.73%	-74.45%	+69.72%
Average Drawdown Average peak-to-trough decline	-6.50%	-86.86%	+80.36%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.33%	15.11%	-12.78%

Volatility

RWL vs. HROW - Volatility Comparison

The current volatility for Invesco S&P 500 Revenue ETF (RWL) is 3.96%, while Harrow Health, Inc. (HROW) has a volatility of 35.91%. This indicates that RWL experiences smaller price fluctuations and is considered to be less risky than HROW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RWL	HROW	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.96%	35.91%	-31.95%
Volatility (6M) Calculated over the trailing 6-month period	7.71%	52.39%	-44.68%
Volatility (1Y) Calculated over the trailing 1-year period	15.13%	64.93%	-49.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.55%	70.23%	-55.68%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.89%	70.72%	-53.83%